Lindsay Ira Golden, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 818 W Diamond Ave, Ste. 120, Gaithersburg, MD 20878 Phone: 301-963-6334 Fax: 301-869-7204 |
Dr. Christopher Kumar Sinha, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 818 W Diamond Ave, Ste 120, Gaithersburg, MD 20878 Phone: 301-963-6334 Fax: 301-869-7204 |
Dr. Mostafa Mahmoud Ahmed, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 818 W Diamond Ave Ste 120, Gaithersburg, MD 20878 Phone: 301-869-7204 |
Michael Harris Arenstein, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 818 W Diamond Ave, Ste. 120, Gaithersburg, MD 20878 Phone: 301-963-6334 Fax: 301-869-7204 |
News Archive
Halt Medical, Inc. announced today that it has been approved to market the Tulip™ Radiofrequency Volumetric Thermal Ablation (RFVTA) probe in Canada. "The license we just received from Health Canada brings us an important step closer to our goal of making our uterine sparing procedure available to the millions of women in North America who suffer with uterine fibroids", said Russ DeLonzor, President and COO of Halt Medical.
There is an increasing prevalence of substance problems in older people but a lack of designated service provision to help treat older addicts highlights an editorial published today in Age & Ageing, the official journal of the British Geriatrics Society.
Supplementing a single protein found in the spinal cord could help prevent symptoms of Lou Gehrig's disease, according to a new study out of Case Western Reserve University School of Medicine.
In the United States, the blood-alcohol limit may be 0.08 percent, but no amount of alcohol seems to be safe for driving, according to a University of California, San Diego sociologist. A study led by David Phillips and published in the journal Addiction finds that blood-alcohol levels well below the U.S. legal limit are associated with incapacitating injury and death.
Illumina, Inc. today announced the launch of the VeriSeq™ NIPT Solution, a CE-IVD marked next-generation sequencing (NGS)-based approach to noninvasive prenatal testing, including CE-IVD marked library prep and analysis software, which enables laboratories in the European Union to bring efficient, highly accurate NIPT in-house.
› Verified 1 days ago